1996
DOI: 10.1016/0014-5793(96)00928-3
|View full text |Cite
|
Sign up to set email alerts
|

Exclusive expression of the Gs‐linked prostaglandin E2 receptor subtype 4 mRNA in human mononuclear Jurkat and KM‐3 cells and coexpression of subtype 4 and 2 mRNA in U‐937 cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

7
20
0

Year Published

2000
2000
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(27 citation statements)
references
References 30 publications
7
20
0
Order By: Relevance
“…Butaprost had no effect on [cAMP] i , suggesting EP2 receptors are not present on Jurkat cells. This is in accordance with earlier findings in which the EP2 receptor was undetectable on Jurkat cells by RT-PCR (48). The fact that the EP1/EP3 agonist 17-P-T-PGE 2 raised [cAMP] i at a dose of 1 M confirms the hypothesis that at high doses, this agonist activates the EP4 receptor, because in human cells EP1 and EP3 receptors do not classically couple to increases in [cAMP] i (49,50).…”
Section: Discussionsupporting
confidence: 92%
See 1 more Smart Citation
“…Butaprost had no effect on [cAMP] i , suggesting EP2 receptors are not present on Jurkat cells. This is in accordance with earlier findings in which the EP2 receptor was undetectable on Jurkat cells by RT-PCR (48). The fact that the EP1/EP3 agonist 17-P-T-PGE 2 raised [cAMP] i at a dose of 1 M confirms the hypothesis that at high doses, this agonist activates the EP4 receptor, because in human cells EP1 and EP3 receptors do not classically couple to increases in [cAMP] i (49,50).…”
Section: Discussionsupporting
confidence: 92%
“…The EP4 receptor has been previously described on Jurkat cells by RT-PCR (48) and flow cytometric analysis (56). To our knowledge, we are the first to describe PGE 2 effects through EP3 on Jurkat cells.…”
Section: Discussionmentioning
confidence: 83%
“…3A). Consistent with these observations, both AH6809 -an antagonist of EP1, EP2 and EP3 (Abramovitz et al, 2000) -and AH23848, which selectively blocks EP4 (Blaschke et al, 1996), alone had no effect on the amount of cells displaying podosomes, whereas they effectively interfered with PGE 2 -induced podosome dissolution (Fig. 3B).…”
Section: Resultssupporting
confidence: 77%
“…Multiple subtypes of the PGE 2 receptor are expressed in cilary epithelial cells (48), osteoblastic cells (49), kerotinocytes (50), fibroblasts (23), and platelets (51). Furthermore, human Jurkat cells express both EP2 and EP4 receptors; however, the expression of EP2 receptor is ϳ100-fold lower than that of EP4 receptors (52). In these cells, the EP4 receptors are the primary receptor subtype mediating the PGE 2 -induced increase in cAMP, whereas EP2 receptors appear to have little or no functional role in PGE 2 -induced cAMP production (52).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, human Jurkat cells express both EP2 and EP4 receptors; however, the expression of EP2 receptor is ϳ100-fold lower than that of EP4 receptors (52). In these cells, the EP4 receptors are the primary receptor subtype mediating the PGE 2 -induced increase in cAMP, whereas EP2 receptors appear to have little or no functional role in PGE 2 -induced cAMP production (52). An analogous situation might exist in sensory neurons.…”
Section: Discussionmentioning
confidence: 99%